Bacterial Infection Probes and Imaging Strategies in Clinical Nuclear Medicine and Preclinical Molecular Imaging

Author(s): Todd A. Sasser, Ashley E. Van Avermaete, Alexander White, Sarah Chapman, James R. Johnson, Tony Van Avermaete, Seth T. Gammon, W. Matthew Leevy

Journal Name: Current Topics in Medicinal Chemistry

Volume 13 , Issue 4 , 2013

Become EABM
Become Reviewer


At present, a limited number of strategies exist for diagnostic imaging of patients with bacterial infection. While radiolabeled probes and white blood cells provide robust solutions to detect bacteria in humans, they also give false positives in cases of sterile inflammation. With the onset of bacterial drug resistance, and a clinical trend toward reducing the prescription of antibiotics, the need for highly specific infection detection protocols has been renewed. The preclinical research community has recently utilized new optical imaging strategies, alongside traditional radioimaging research, to develop novel infection probes with translational potential. Here we review the current clinical methods for imaging bacteria in humans, and discuss the efforts within the preclinical community to validate new strategies. The review of preclinical infection imaging probes is limited to those probes that could be feasibly adapted for use in humans with currently available clinical modalities.

Keywords: Bacterial infection, in vivo molecular imaging, nuclear medicine, probe development.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [479 - 487]
Pages: 9
DOI: 10.2174/1568026611313040008
Price: $65

Article Metrics

PDF: 30